Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193805-25-000542
Filing Date
2025-04-22
Accepted
2025-04-22 17:15:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 e664424_defa14a-immunic.htm DEFA14A 8773
2 GRAPHIC image_1.jpg GRAPHIC 119827
3 GRAPHIC image_2.jpg GRAPHIC 76900
  Complete submission text file 0001193805-25-000542.txt   281060
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36201 | Film No.: 25858564
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)